尿液C4d与IgA血管炎肾病进展相关
本研究纳入139例IgA血管炎肾炎(IgAVN)患者,并设18例健康对照、23例局灶节段性肾小球硬化及38例IgA肾病患者,检测肾活检时尿C4d/肌酐水平。中位随访52.79个月,18例(12.95%)达到复合肾脏病进展事件。
要点
- 尿C4d/Cr在IgAVN和IgAN患者中高于健康对照。
- 尿C4d/Cr升高与更重蛋白尿、牛津C病变及肾小球C4d沉积相关。
- 校正临床数据后,尿C4d/Cr升高与IgAVN肾脏病进展风险增加独立相关。
核心结论
- 尿C4d/Cr水平升高与IgAVN患者肾脏病进展事件相关。
研究设计与样本
- 研究纳入139例IgAVN患者,并设18例健康对照、23例局灶节段性肾小球硬化患者和38例IgAN患者。
- 采用酶联免疫吸附法检测肾活检时尿C4d水平,以尿C4d/肌酐评估与肾脏病进展事件的关联。
- 肾脏病进展事件定义为估算肾小球滤过率下降40%或终末期肾病。
- 采用Cox比例风险模型和限制性立方样条评估关联。
主要发现
- IgAVN和IgAN患者尿C4d/Cr水平高于健康对照。
- 尿C4d/Cr较高与较高蛋白尿、严重牛津C病变及肾小球C4d沉积相关。
- 中位随访52.79个月,18例(12.95%)达到复合肾脏病进展事件。
临床怎么用
- 尿C4d/Cr或可作为IgAVN肾脏病进展风险分层的生物标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Immunoglobulin A (IgA) vasculitis nephritis (IgAVN) is the most common secondary IgA nephropathy (IgAN). Urinary C4d have been identified associated with the development and progression in primary IgAN; however, its role in kidney disease progression of IgAVN is still unclear. METHODS: This study enrolled 139 patients with IgAVN, 18 healthy subjects, 23 focal segmental glomerulosclerosis patients and 38 IgAN patients. Urinary C4d levels at kidney biopsy were measured using enzyme-linked immunosorbent assay. The association between urinary C4d/creatinine and kidney disease progression event, defined as 40% estimated glomerular filtration rate decline or end-stage kidney disease, was assessed using Cox proportional hazards models and restricted cubic splines. RESULTS: The levels of urinary C4d/creatinine (Cr) in IgAVN and IgAN patients were higher than in healthy controls. Higher levels of urinary C4d/Cr were associated with higher proteinuria and severe Oxford C lesions, and glomerular C4d deposition. After a median follow-up of 52.79 months, 18 (12.95%) participants reached composite kidney disease progression event. The risk of kidney disease progression event was higher with higher levels of Ln(urinary C4d/Cr). After adjustment for clinical data, higher levels of urinary C4d/Cr were associated with kidney disease progression in IgAVN [per Ln-transformed urinary C4d/Cr, hazard ratio 1.573, 95% confidence interval (CI) 1.101-2.245; P = .013]. Compared with the lower C4d/Cr group, the hazard ratio was 5.539 (95% CI 1.135-27.035; P = .034) for the higher levels group. CONCLUSIONS: Higher levels of urinary C4d/Cr were associated with kidney disease progression event in patients with IgAVN.
引用
- Yu G, Zhao J, Wang M, et al. Urinary C4d and progression of kidney disease in IgA vasculitis. Nephrol Dial Transplant. 2024. PMID: 38373839. doi:10.1093/ndt/gfae045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。